Trial · NCT05674487
Prostaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction (PROBIN)
NCT05674487, Not applicable, Recruiting, University Hospital, Bordeaux
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Prostaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction (PROBIN). Trials, record NCT05674487. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05674487
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Prostaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction (PROBIN)
- NCT number
- NCT05674487
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 774 participants, estimated
- Lead sponsor
- University Hospital, Bordeaux
- Conditions
- Fetal Growth Restriction
- Interventions
- Trans-cervical balloon, Misoprostol
- First posted
- 2023-01-06
- Last updated
- 2025-04-02
Source ClinicalTrials.gov
Registered outcomes33
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | cesarean section | Day 1 | Incidence of cesarean section defined as a cesarean birth regardless of the indication |
| Secondary | duration of labor | Day 1 | Mean duration of labor (duration between admission to the labor room and delivery) |
| Secondary | duration between cervical ripening and delivery | Day 1 | Mean duration between cervical ripening and delivery |
| Secondary | oxytocin use | Day 1 | Incidence of oxytocin use (median of the maximal administered dosage) |
| Secondary | operative delivery | Day 1 | Incidence of operative delivery (vacuum, forceps, spatula) |
| Secondary | postpartum hemorrhage | Day 3 | Incidence of postpartum hemorrhage defined by blood loss \>500mL (defined according to the CNGOF criteria) |
| Secondary | Mean total blood loss | Day 3 | Mean total blood loss (mL) |
| Secondary | intra-uterine infectious | Day 5 | Incidence of intra-uterine infectious defined by a fever (maternal temperature equal to or greater than 38°C twice), associated to at least one of the two criterion: persistent fetal tachycardia \> 160 bpm, or purulent amniotic fluid (defined according to the CNGOF criteria). |
| Secondary | iron administration | Day 5 | Incidence of postpartum intravenous iron administration |
| Secondary | transfusion | Day 5 | Incidence of transfusion of blood products or blood |
1 to 10 of 33Source ClinicalTrials.gov
See all 33 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 41664013 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05674487
GET https://conductscience.org/api/trials/v1/NCT05674487/registered?page=2